Standout Papers
Immediate Impact
62 standout
Citing Papers
Pancreatic cancer
2025 Standout
Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
2025 Standout
Works of Federica Morano being referenced
Updated results and subgroup analysis by presence of liver metastases of a phase I/II study of the EP4 antagonist vorbipiprant with the anti-PD-1 balstilimab in mismatch-repair-proficient and microsatellite stable (pMMR/MSS) chemorefractory metastatic colorectal cancer (mCRC).
2024
NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer
2024 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Federica Morano | 475 | 335 | 422 | 76 | 1.1k | |
| Bala Başak Öven Ustaalıoğlu | 509 | 424 | 355 | 84 | 1.1k | |
| Cosimo Sacco | 516 | 381 | 210 | 59 | 1.1k | |
| SP Stenning | 383 | 517 | 454 | 39 | 1.3k | |
| Mesut Şeker | 598 | 473 | 399 | 97 | 1.3k | |
| Peter Kozuch | 541 | 256 | 244 | 41 | 1.0k | |
| Eun‐Kee Song | 615 | 371 | 273 | 77 | 1.3k | |
| Gun Min Kim | 753 | 521 | 210 | 90 | 1.3k | |
| Ebbe Lindegaard Madsen | 287 | 308 | 540 | 34 | 907 | |
| Fabio Carboni | 412 | 517 | 561 | 80 | 1.0k | |
| M. R. Moore | 417 | 279 | 223 | 38 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...